The Access Group Launches Two New Companies--FronTier Managed Markets and Bioeclipse--to Further Compliment Its Portfolio of Services
New full-service companies deliver expertise in managed markets and biopharma
BERKELEY HEIGHTS, N.J., Nov. 13, 2014 /PRNewswire/ -- The Access Group (www.theaccessgp.com) is proud to announce the launch today of two new full-service entities—FronTier Managed Markets and Bioeclipse—that will further expand and compliment the capabilities of the firm as a leading provider of complete lifecycle management for products in the pharmaceutical, biopharma, and medical device industries.
"Today's launch further advances the evolution and maturation of the Access Group as the premier partner in collaborative integrated services," said Dave Gagliano, President and Chief Executive Officer of the Access Group. "The continued success we have experienced is a testament to having been chosen by our partner clients for our wide breadth of complimentary services that help to shepherd their products through their lifecycles. Now, with the addition of FronTier Managed Markets and Bioeclipse, and the intellect that the leadership of these entities brings to bear, the Access Group will continue to differentiate itself from the competition."
FronTier Managed Markets Translates Expertise Into Success
Today's market shifts in the health care landscape are significant—policies and customers are evolving, with emerging models of care leading this transformation. FronTier Managed Markets brings substantial experience combined with a thorough understanding of the stakeholders who are altering this landscape, from health plan medical directors to integrated networks to large physician groups.
"You can't fake it with managed markets, especially in 2014," said Seth Gordon, the company lead for FronTier Managed Markets and a Managing Partner at the Access Group. "In order to truly help clients navigate everything from coinsurance to the nuances in restrictions and benefit designs, you need a strong experiential set in this space, coupled with best-in-class clinical, policy, copy, and creative ideation. We are able to provide that with FronTier Managed Markets and better prepare our clients for what lies ahead in the US reimbursement space."
FronTier Managed Markets is based out of the Access Group headquarters in NJ. Learn more about FronTier Managed Markets by visiting the Access Group website or contacting Seth Gordon at [email protected].
Bioeclipse Delivers Access and Reimbursement Roadmaps for Biotechnology and Oncology Specialty Drugs
The biopharma and oncology treatments reaching the market today are new and novel agents that fill vast unmet needs with tremendous promise for all stakeholders involved in a patient's care. Manufacturers of these products require expertise to prepare for market launch so that they can optimize access and reimbursement. Bioeclipse offers a deep and complete understanding of the complex needs and evolving issues in the specialty, biologic, and oncologic marketplaces to deliver results-driven solutions in all the payer customer channels.
"With more than 600 new molecular compounds already in or entering into phase 3 in the oncology development area, coupled with the fact that soon more than 60% of a health plan's budget will be allotted to pay for specialty and oncologic agents in the next few years, it is an exciting time to launch a new entity devoted to this unique space," said Mike Webster, the company lead for Bioeclipse and a Managing Partner at the Access Group. "Issues such as clinical pathways, restrictions to specific patient populations, specialty pharmacy distribution, and benefit-to-cost analyses will soon be the 'new norm' for pharma. Having a company like Bioeclipse allows for the Access Group to remain on the cutting edge of reimbursement initiatives and the payer marketing world of tomorrow."
Bioeclipse is based out of the Access Group headquarters in NJ. Learn more about Bioeclipse by visiting the Access Group website or contacting Mike Webster at [email protected].
About the Access Group
The Access Group is the leading independent strategic health care communications network composed of 8 distinct companies: Access Alliance, Bioeclipse, Catalyst, FronTier Managed Markets, MedAccess, Promidian, S3 — Strategic Selling Solutions, and StrataMed. The firm employs more than 90 health care marketing specialists, consultants, and senior leaders with experience in management consulting, medical education, marketing communications, managed markets, training, and brand promotion.
The Access Group is headquartered in Berkeley Heights, New Jersey, with offices in New York City, Chicago, San Diego, Los Angeles, and San Francisco. To learn more about the firm, please visit www.theaccessgp.com or contact Dave Gagliano, President and CEO, at (908) 508-6700.
SOURCE The Access Group
Share this article